356560-80-0

Basic information

• Product Name: 6-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE
• Synonyms: 6-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE;6-Bromo[1,2,4]triazolo[1,5-a]pyridine 96%;6-Bromo[1,2,4]triazolo[1,5-α]pyridine;6-BroMo[1,2,4]triazolo[1,...;[1,2,4]Triazolo[1,5-a]pyridine,6-broMo-
• CAS NO: 356560-80-0
• Molecular Formula: C₆H₄BrN₃
• Molecular Weight: 198.02006
• Product Categories: blocks;Bromides;Pyridines;Heterocyclic Compounds;Bases & Related Reagents;Heterocycles;Nucleotides;Heterocycle-Pyridine series
• Mol File: 356560-80-0.mol

Chemical Properties

• Melting Point: 100-102
• Appearance: /Solid
• Density: 1.891 g/cm³
• Refractive Index: 1.751
• Storage Temp.: Keep Cold
• PKA: 1.46±0.30(Predicted)
• CAS DataBase Reference: 6-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE(356560-80-0)
• EPA Substance Registry System: 6-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE(356560-80-0)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-36/37/38
• Safety Statements: 26-24/25
• WGK Germany: 3
• Hazardous Substances Data: 356560-80-0(Hazardous Substances Data)

Usage

Chemical Properties

Off-white powder

Uses

A selective inhibitor of ALK5 kinase

InChI:InChI=1/C6H4BrN3/c7-5-1-2-6-8-4-9-10(6)3-5/h1-4H

Upstream product

• 382592-25-8 N-(5-bromopyrid-2-yl)formamidoxime 
• 1072-97-5 5-bromo-2-pyridylamine 
• 138888-98-9 N’-(5-bromopyridin-2-yl)-N,N-dimethylformimidamide 
• 1075260-65-9 N-(5-bromo-2-pyridinyl)imidoformamide 

Downstream Products

• 899429-13-1 tert-butyl [(1S,2S)-1-[(3,3-difluoropyrrolidin-1-yl)carbonyl]-3-(dimethylamino)-3-oxo-2-(4-[1,2,4]triazolo[1,5-a]pyridine-6-phenyl)propyl]carbamate 
• 690258-08-3 1-[(2S,3S and 3R)-2-(tert-butoxycarbonylamino)-3-carboxy-3-(4-[1,2,4]triazolo[1,5-a]pyridin-6-ylphenyl)1-oxopropanyl]-3,3-difluoropyrrolidine 
• 1084812-38-3 C₂₈H₂₁F₂N₅O₅S 
• 943845-23-6 [1,2,4]triazolo[1,5-a]pyridine-6-carbonitrile 
• 1160790-18-0 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo-[1,5-a]pyridine 
• 1190380-46-1 1,1-diphenyl-N-([1,2,4]triazolo[1,5-a]pyridin-6-yl)methanimine 
• 1236325-03-3 (S)-3-((S)-1-(4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl)ethyl)-6-(2-hydroxy-2-methylpropyl)-6-phenyl-1,3-oxazinan-2-one 
• 1255923-87-5 4-(3,4-dichlorophenyl)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1,1-dimethyl-1,2,3,4-tetrahydroisoquinoline 
• 1043903-19-0 [1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid 
• 1454284-56-0 [1,2,4]triazolo[1.5-a]pyridine-6-carboxylic acid 4-benzenesulfonylbenzylamide 
• 1202704-15-1 (S)-(N-3-(3-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl)-2-oxo-5-oxazolidinyl)methylacetamide 
• 1202704-50-4 (R)-3-(3-Fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl)-5-([1,2,3]triazol-1-yl)methyloxazolidin-2-one 
• 870773-62-9 cis-tert-butyl [(1S,2S)-1-[(3,3-difluoropyrrolidin-1-yl)carbonyl]-3-(dimethylamino)-3-oxo-2-(4-[1,2,4]triazolo[1,5-a]pyridin-6-cyclohexyl)propyl]carbamate 
• 870773-63-0 trans-tert-butyl [(1S,2S)-1-[(3,3-difluoropyrrolidin-1-yl)carbonyl]-3-(dimethylamino)-3-oxo-2-(4-[1,2,4]triazolo[1,5-a]pyridin-6-cyclohexyl)propyl]carbamate 

Relevant articles and documents

Novel pyridinyl triazolopyridine derivatives and use thereof

The present invention relates to novel pyridinyl-triazolopyridine derivatives and uses thereof, and more specifically, to an aromatic organic material including pyrimidine and an organic electroluminescent device using the same. According to an embodiment of the present invention, the organic electroluminescent device using the aromatic organic material including the pyrimidine can obtain light at a short wavelength in a highly efficient manner while lowering the driving voltage.COPYRIGHT KIPO 2019

AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES

Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds.

AMIDO-BENZYL SULFONE AND SULFONAMIDE DERIVATIVES

Disclosed are certain amido-benzyl sulfone and sulfonamide compounds, pharmaceutical compositions comprising such compounds, land methods of treatment using such compounds.

AMIDO-BENZYL SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment of an NAMPT-mediated disease or condition in a subject, selected from solid or liquid tumor, rheumat

ALKYL-AND DI-SUBSTITUTED AMIDO-BENZYL SULFONAMIDE DERIVATIVES

The present invention relates to certain alkyl- and di-substituted amido-benzyl sulfonamide compounds, pharmaceutical compositions comprising such compounds, and to methods of treatment of NAMPT-mediated disorders, such as diabetes, rheumatoid arthritis,

SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF

The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.

CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF

Novel [1,2,4]triazolo[1,5-a]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SA1 and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-1 and N-2 are also described in the present invention.

ARYL, HETEROARYL, AND HETEROCYCLE SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF

Novel aryl, heteroaryl, and non-aromatic heterocyle substituted tetrahydroisoquinolines are described in the present invention. These compounds are used in the treatment of various neurological and physiological disorders. Methods of making these compounds are also described in the present invention.

7-([1,2,4,]TRIAZOLO[1,5,-A]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF

Novel [l,2,4]triazolo[l,5-α]pyridinyl-6-yl-substituted tetrahydroisoquinolines are described in the present invention. These compounds and crystalline forms SAl and N-2 are used in the treatment of various neurological and physiological disorders. Methods of making these compounds and crystalline forms SA-I and N-2 are also described in the present invention.